ALA 1.61% 15.3¢ arovella therapeutics limited

sud oversold, page-59

  1. 4,730 Posts.
    lightbulb Created with Sketch. 242
    Hi jsbuser

    Yes, there most certainly has been a tremendous rise in the potential application of ArTiMist subject to a trial.

    kippax
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.